Hanna Rafaela Ferreira Dalla Pria MD, Otavio Augusto Ferreira Dalla Pria MD, Jitesh Ahuja MD, Rishi Agrawal MD, Chad D. Strange MD, Melissa C. Price MD, Mylene T. Truong MD
PET/computed tomography (CT) with [18F]-fluoro-2-deoxy-d-glucose (FDG) has become indispensable for evaluating malignancies, particularly in staging, monitoring treatment response, and detecting tumor recurrence.1, 2, 3